The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 269.50
Bid: 267.50
Ask: 268.50
Change: 6.00 (2.28%)
Spread: 1.00 (0.374%)
Open: 257.00
High: 269.50
Low: 257.00
Prev. Close: 263.50
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of GM

11 Jul 2022 15:54

RNS Number : 0680S
CMC Markets Plc
11 July 2022
 

11 July 2022

 

CMC MARKETS PLC

 

NOTICE OF GENERAL MEETING TO APPROVE PROPOSED RELATED PARTY TRANSACTION AND AUDITOR'S STATEMENT OF REASONS

 

CMC Markets plc (the "Company"), announces that the following documents are being posted or otherwise made available to shareholders:

· Notice of General Meeting to approve proposed related party transaction ("GM");

· Auditor's statement of their reasons for ceasing to hold office ("Statement of Reasons"); and

· Notice of Availability.

Pursuant to Listing Rule 9.6.1R, copies of the Notice of GM, Statement of Reasons and Notice of Availability have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Notice of GM, Statement of Reasons and Notice of Availability can also be viewed on the Company's website at www.cmcmarketsplc.com/investors.

The GM will be held at 133 Houndsditch, London, EC3A 7BX on Thursday 28 July 2022 at 10.30 a.m. (or as soon thereafter as the Annual General Meeting of the Company convened for 10.00 a.m. on that day has been concluded or adjourned).

The Board of CMC Markets plc ("the Board") is looking forward to welcoming shareholders in person to the GM. However, in the event that government restrictions on public gatherings or other social distancing measures are reintroduced, the Company may be required to change the arrangements for the Meeting at short notice. Any changes to the arrangements set out in the Notice of GM will be communicated to shareholders via the Company's website www.cmcmarketsplc.com/investors/shareholder-information/#AGM and announced via a regulatory news service. Further information can be found in the Notice of GM.

As noted in the Directors' Report for the year ended 31 March 2022, the Board has discovered a procedural oversight in respect of the Company's processes for the payment of certain past dividends, namely that the FY17 interim dividend paid on 23 December 2016, the FY18 interim dividend paid on 22 December 2017 and the FY21 interim dividend paid on 18 December 2020 (together, the "Relevant Dividends") were made otherwise than in accordance with the strict formalities of the Companies Act 2006 (the "Act"). 

In relation to the Relevant Dividends, the interim accounts were not filed at Companies House as required by the Act, although in each case interim accounts were prepared which demonstrated sufficient distributable reserves. The omission of filing interim accounts constitutes a procedural breach of the Act. In aggregate, the unlawful component of all three Relevant Dividends is £33,968,171.

 

The Company has been advised that, as a consequence of the Relevant Dividends having procedurally been made otherwise than in accordance with the Act, it may have claims against past and present shareholders who were recipients of the Relevant Dividends and against persons who were directors of the Company at the time of the payment of the Relevant Dividends. It is therefore proposed that the Company enter into deeds of release such that the Company will be unable to make any claims against:

1) past and present shareholders of the Company who were recipients of the Relevant Dividends, including Lord Peter Cruddas, Lady Fiona Cruddas and other members of the Cruddas family (who are related parties of the Company as substantial shareholders); and

2) the directors of the Company (excluding Susanne Chishti) and the former directors of the Company in office at the time of any Relevant Dividend, in each case in respect of the payment of the Relevant Dividend otherwise than in accordance with the Act. The current directors are related parties of the Company, being James Richards, David Fineberg, Peter Cruddas, Sarah Ing, Clare Salmon, Paul Wainscott., Euan Marshall and Matthew Lewis.

The Company has today published a Notice of GM convening a General Meeting at which a resolution will be proposed which will, if passed, give the Board authority to enter into a directors' deed of release (the "Directors' Deed of Release") and a shareholders' deed of release (the "Shareholders' Deed of Release") and put all potentially affected parties so far as possible in the position in which they were always intended to be had the Relevant Dividends been made in accordance with the procedural requirements of the Act (the "Resolution"). The Company's entry into the Directors' Deed of Release and the Shareholders' Deed of Release will not have any effect on the Company's financial position. 

The entry into the Directors' Deed of Release and the Shareholders' Deed of Release constitute related party transactions under the FCA's Listing Rules, and specifically fall within Listing Rule 11.1.10R. Therefore the Resolution will also seek the specific approval for the entry into the Directors' Deed of Release and Shareholders' Deed of Release as related party transactions, in accordance with the Listing Rules.

The approach that the Company is proposing is in line with the approach taken by other UK incorporated listed companies which have discovered past dividends were made otherwise than in strict accordance with the Act.

 

 

For further information contact:

 

Patrick Davis

General Counsel & Company Secretary

CMC Markets plc

+ 44 (0) 20 7170 8200

LEI Number: 213800VB75KAZBFH5U07

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGKZGMNDMMGZZM
Date   Source Headline
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement
21st Jul 202311:20 amRNSDirector/PDMR Shareholding
21st Jul 202310:07 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
7th Jul 202310:09 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSDirectorate Change
23rd Jun 20235:09 pmRNSNotice of AGM
13th Jun 20237:00 amRNSFinal Results
9th Jun 20237:00 amRNSInvestment in StrikeX Technologies
6th Jun 20231:48 pmRNSDirector/PDMR Shareholding
9th May 20231:34 pmRNSDirector/PDMR Shareholding
6th Apr 20233:40 pmRNSDirector/PDMR Shareholding
31st Mar 202310:56 amRNSHolding(s) in Company
27th Mar 20233:51 pmRNSTrading Statement
7th Mar 20232:49 pmRNSDirector/PDMR Shareholding
7th Feb 202311:37 amRNSDirector/PDMR Shareholding
25th Jan 20237:00 amRNSTrading Statement
9th Jan 20232:15 pmRNSDirector/PDMR Shareholding
9th Jan 202312:50 pmRNSDirector/PDMR Shareholding
6th Jan 20233:22 pmRNSDirector/PDMR Shareholding
14th Dec 202212:38 pmRNSDirectorate Change
6th Dec 20222:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.